Tag: Venture Capital Funding

Phunware has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $30,000,000.00 in Post-IPO Equity.

Phunware has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $30,000,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, Phunware is raising $30,000,000.00 in new funding. About Phunware: Phunware, Inc., together with its subsidiaries, offers integrated software platform that equips companies with the products,…

Read More Read More

NetList has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $30,000,000.00 in Post-IPO Equity.

NetList has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $30,000,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, NetList is raising $30,000,000.00 in new funding. About NetList: Netlist, Inc. designs, manufactures, and markets memory subsystems for the server, high-performance computing, and communications markets…

Read More Read More

Contango ORE has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $30,400,000.00 in Post-IPO Equity.

Contango ORE has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $30,400,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, Contango ORE is raising $30,400,000.00 in new funding. About Contango ORE: Contango Ore, Inc., an exploration stage company, engages in the exploration of gold and…

Read More Read More

Inozyme Pharma has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $64,500,000.00 in Post-IPO Equity.

Inozyme Pharma has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $64,500,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, Inozyme Pharma is raising $64,500,000.00 in new funding. About Inozyme Pharma: Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the…

Read More Read More

Immatics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $35,000,000.00 in Post-IPO Equity.

Immatics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $35,000,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, Immatics is raising $35,000,000.00 in new funding. About Immatics: Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell…

Read More Read More

Nikola Corporation has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $50,000,000.00 in Post-IPO Equity.

Nikola Corporation has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $50,000,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, Nikola Corporation is raising $50,000,000.00 in new funding. About Nikola Corporation: Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation…

Read More Read More

Velo3D has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $70,000,000.00 in Post-IPO Equity.

Velo3D has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $70,000,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, Velo3D is raising $70,000,000.00 in new funding. About Velo3D: Velo3D, Inc. produces metal additive three dimensional printers in the United States and internationally. The company’s…

Read More Read More

AN2 Therapeutics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $70,000,000.00 in Post-IPO Equity.

AN2 Therapeutics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $70,000,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, AN2 Therapeutics is raising $70,000,000.00 in new funding. About AN2 Therapeutics: AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic,…

Read More Read More

Turnstone Biologics has filed a notice of an Initial Public Offering of securities to raise $80,000,000.00 in new Equity.

Turnstone Biologics has filed a notice of an Initial Public Offering of securities to raise $80,000,000.00 in new Equity.

According to filings with the U.S. Securities and Exchange Commission, Turnstone Biologics is raising $80,000,000.00 in new funding. About Turnstone Biologics: Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure…

Read More Read More

Tango Therapeutics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $80,000,000.00 in Post-IPO Equity.

Tango Therapeutics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $80,000,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, Tango Therapeutics is raising $80,000,000.00 in new funding. About Tango Therapeutics: Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of…

Read More Read More